Press Releases

SEATTLE, Sept. 5, 2019 /PRNewswire/ -- More than 90% of people who died by suicide showed symptoms of mental health conditions, yet 59% of US adults with a mental health condition received no mental health services in the past year, according to a new

CMAB Biopharma today reports a positive opinion from a recent QP audit conducted by Parexel International Co. CMAB's fully integrated CDMO facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 Good Manufacturing Practice (GMP) guidelines This achievement signals CMAB Biopharma's continuing evolution into an international CDMO capable

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- The nation's top business leaders recently endorsed a more modern view of

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- Childhood cancer is more prevalent than previously believed, with global estimates of more than 400,000 new cases diagnosed every year, according to new research from St. Jude Children's Hospital and the University of Washington. In an effort to illustrate and explore the scope of the crisis, U.S

SEATTLE and VANCOUVER, British Columbia, Sept. 5, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the Company will host its first investor day on

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019. The 10 largest shareholders in InDex Pharmaceuticals Holding AB (publ) were per August 30, 2019 of

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Sigrid Therapeutics AB, an innovative technology company developing a new class of products to improve human health, including type 2 diabetes, today announces an equity financing round of USD 1.6M. The two times oversubscribed financing round was led by Joyance Partners, a US-based venture c

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his position in Octob

KRAKOW, Poland, Sept. 5, 2019 /PRNewswire/ -- Selvita (WSE: SLV) today reported second quarter 2019 financial results and provided a corporate update. "We continue to execute on the priorities we set out early in the year," commented Pawel Przewiezlikowski, Chief Executive Officer of Selvita. "We expect to see our oncology therapeutics and research servic

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- Today during the ADA FDI World Dental Congress in San Francisco, USA, FDI World Dental Federation (FDI) released its latest resources on the treatment and care of patients with partial tooth loss.